Login / Signup

Microcirculation Improvement in Diabetic Foot Patients after Treatment with Sucrose Octasulfate-Impregnated Dressings.

José Luis Lázaro MartínezMarta García-MadridSerge BohbotMateo López-MoralFrancisco Javier Álvaro AfonsoYolanda García Álvarez
Published in: Journal of clinical medicine (2023)
To assess the patients' microcirculation evolution during the treatment with a sucrose octasulfate-impregnated dressing, fifty patients with neuroischaemic DFU treated with TLC-NOSF dressing were included in a prospective study between November 2020 and February 2022. TcpO 2 values were measured on the dorsalis pedis or tibial posterior arteries' angiosome according to the ulcer location. TcpO 2 values were assessed at day 0 and every 4 weeks during 20 weeks of the follow-up or until the wound healed. A cut-off point of tcpO 2 < 30 mmHg was defined for patients with impaired microcirculation. The TcpO 2 values showed an increase between day 0 and the end of the study, 33.04 ± 12.27 mmHg and 40.89 ± 13.06 mmHg, respectively, p < 0.001. Patients with impaired microcirculation showed an increase in the tcpO 2 values from day 0 to the end of the study ( p = 0.023). Furthermore, we observed a significant increase in the TcpO 2 values in the forefoot DFU ( p = 0.002) and in the rearfoot DFU ( p = 0.071), with no difference between the ulcer locations ( p = 0.694). The local treatment with TLC-NOSF dressing improved the microcirculation in patients with neuroischaemic DFU, regardless of microcirculation status at the baseline, and in the forefoot, regardless of the location.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • peritoneal dialysis
  • combination therapy
  • patient reported